Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Chinese Patent Office

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,371,361

« Back to Dashboard

Title:Method of producing FR901228
Abstract: Depsipeptides and congeners thereof are disclosed having structure (I), wherein m, n, p, q, X, R1, R2 and R3 are as defined herein. These compounds, including FR901228, have activity as, for example, immunosuppressants, as well as for the prevention or treatment of patients suffering or at risk of suffering from inflammatory, autoimmune or immune system-related diseases including graft-versus-host disease and enhancement of graft/tissue survival following transplant. Also provided are methods for inhibiting lymphocyte activation, proliferation, and/or suppression of IL-2 secretion.
Inventor(s): Ueda; Satoshi (Chuo-ku, JP), Watamoto; Yoko (Chuo-ku, JP), Tsuboi; Masaru (Chuo-ku, JP), Kanda; Munekazu (Chuo-ku, JP), Higaki; Tomoji (Chuo-ku, JP), Matsuda; Mitsunori (Chuo-ku, JP)
Assignee: ASTELLAS PHARMA INC. (Chuo-ku, JP)
Filing Date:Apr 21, 2015
Application Number:14/692,055
Claims:1. A method of producing type A crystalline form of FR901228: ##STR00002## comprising: culturing a producing strain for FR901228 in a medium to which at least one amino acid selected from the group consisting of L-arginine, an acid addition salt of L-arginine, L-histidine, an acid addition salt of L-histidine, L-cystine, an acid addition salt of L-cystine, L-cysteine, and an acid addition salt of L-cysteine, has been added; isolating and purifying FR901228 from the medium; and crystallizing to obtain the type A crystalline form of FR901228 from a solution of FR901228 comprising ethanol and water, or acetone and water.

2. The method of claim 1, wherein the type A crystalline form of FR901228 exhibits a powder X-ray diffraction pattern substantially similar to FIG. 3.

3. The method of claim 1, wherein the at least one amino acid comprises at least one of L-cysteine and an acid addition salt thereof in an amount greater than other amino acids.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.